1
|
Zhang X and Mosser DM: Macrophage
activation by endogenous danger signals. J Pathol. 214:161–178.
2008. View Article : Google Scholar : PubMed/NCBI
|
2
|
Fujihara M, Muroi M, Tanamoto K, Suzuki T,
Azuma H and Ikeda H: Molecular mechanisms of macrophage activation
and deactivation by lipopolysaccharide: Roles of the receptor
complex. Pharmacol Ther. 100:171–194. 2003. View Article : Google Scholar : PubMed/NCBI
|
3
|
Park BS and Lee JO: Recognition of
lipopolysaccharide pattern by TLR4 complexes. Exp Mol Med.
45:e662013. View Article : Google Scholar : PubMed/NCBI
|
4
|
Kapadia M and Sakic B: Autoimmune and
inflammatory mechanisms of CNS damage. Prog Neurobiol. 95:301–333.
2011. View Article : Google Scholar : PubMed/NCBI
|
5
|
Laveti D, Kumar M, Hemalatha R, Sistla R,
Naidu VG, Talla V, Verma V, Kaur N and Nagpal R: Anti-inflammatory
treatments for chronic diseases: A review. Inflamm Allergy Drug
Targets. 12:349–361. 2013. View Article : Google Scholar : PubMed/NCBI
|
6
|
Muralidharan S and Mandrekar P: Cellular
stress response and innate immune signaling: Integrating pathways
in host defense and inflammation. J Leukoc Biol. 94:1167–1184.
2013. View Article : Google Scholar : PubMed/NCBI
|
7
|
Guha M and Mackman N: LPS induction of
gene expression in human monocytes. Cell Signal. 13:85–94. 2001.
View Article : Google Scholar : PubMed/NCBI
|
8
|
Li Q and Verma IM: NF-kappaB regulation in
the immune system. Nat Rev Immunol. 2:725–734. 2002. View Article : Google Scholar : PubMed/NCBI
|
9
|
Caivano M: Role of MAP kinase cascades in
inducing arginine transporters and nitric oxide synthetase in
RAW264 macrophages. FEBS Lett. 429:249–253. 1998. View Article : Google Scholar : PubMed/NCBI
|
10
|
Uto T, Fujii M and Hou DX:
6-(Methylsulfinyl)hexyl isothiocyanate suppresses inducible nitric
oxide synthase expression through the inhibition of Janus kinase
2-mediated JNK pathway in lipopolysaccharide-activated murine
macrophages. Biochem Pharmacol. 70:1211–1221. 2005. View Article : Google Scholar : PubMed/NCBI
|
11
|
Choi J, Kim TH, Choi TY and Lee MS:
Ginseng for health care: A systematic review of randomized
controlled trials in Korean literature. PLoS One. 8:e599782013.
View Article : Google Scholar : PubMed/NCBI
|
12
|
Coleman CI, Hebert JH and Reddy P: The
effects of Panax ginseng on quality of life. J Clin Pharm
Ther. 28:5–15. 2003. View Article : Google Scholar : PubMed/NCBI
|
13
|
Kitts D and Hu C: Efficacy and safety of
ginseng. Public Health Nutr. 3(4A): 473–485. 2000. View Article : Google Scholar : PubMed/NCBI
|
14
|
Shibata S: Chemistry and cancer preventing
activities of ginseng saponins and some related triterpenoid
compounds. J Korean Med Sci. 16:S28–37. 2001. View Article : Google Scholar : PubMed/NCBI
|
15
|
Chen RJ, Chung TY, Li FY, Lin NH and Tzen
JT: Effect of sugar positions in ginsenosides and their inhibitory
potency on Na+/K+-ATPase activity. Acta
Pharmacol Sin. 30:61–69. 2009. View Article : Google Scholar : PubMed/NCBI
|
16
|
Lü JM, Yao Q and Chen C: Ginseng
compounds: An update on their molecular mechanisms and medical
applications. Curr Vasc Pharmacol. 7:293–302. 2009. View Article : Google Scholar : PubMed/NCBI
|
17
|
Kim JY, Lee HJ, Kim JS and Ryu JH:
Induction of nitric oxide synthase by saponins of heat-processed
ginseng. Biosci Biotechnol Biochem. 69:891–895. 2005. View Article : Google Scholar : PubMed/NCBI
|
18
|
Park JS, Park EM, Kim DH, Jung K, Jung JS,
Lee EJ, Hyun JW, Kang JL and Kim HS: Anti-inflammatory mechanism of
ginseng saponins in activated microglia. J Neuroimmunol. 209:40–49.
2009. View Article : Google Scholar : PubMed/NCBI
|
19
|
Kang A, Hao H, Zheng X, Liang Y, Xie Y,
Xie T, Dai C, Zhao Q, Wu X, Xie L and Wang G: Peripheral
anti-inflammatory effects explain the ginsenosides paradox between
poor brain distribution and anti-depression efficacy. J
Neuroinflammation. 8:1002011. View Article : Google Scholar : PubMed/NCBI
|
20
|
Sugimoto S, Nakamura S, Matsuda H,
Kitagawa N and Yoshikawa M: Chemical constituents from seeds of
Panax ginseng: Structure of new dammarane-type triterpene
ketone, panaxadione, and hplc comparisons of seeds and flesh. Chem
Pharm Bull (Tokyo). 57:283–287. 2009. View Article : Google Scholar : PubMed/NCBI
|
21
|
Dinarello CA: Proinflammatory cytokines.
Chest. 118:503–508. 2000. View Article : Google Scholar : PubMed/NCBI
|
22
|
Koppula S, Kumar H, Kim IS and Choi DK:
Reactive oxygen species and inhibitors of inflammatory enzymes,
NADPH oxidase, and iNOS in experimental models of Parkinson's
disease. Mediators Inflamm. 823902:20122012.
|
23
|
Martinon F: Signaling by ROS drives
inflammasome activation. Eur J Immunol. 40:616–619. 2010.
View Article : Google Scholar : PubMed/NCBI
|
24
|
Korbecki J, Baranowska-Bosiacka I,
Gutowska I and Chlubek D: The effect of reactive oxygen species on
the synthesis of prostanoids from arachidonic acid. J Physiol
Pharmacol. 64:409–421. 2013.PubMed/NCBI
|
25
|
Marcus JS, Karackattu SL, Fleegal MA and
Sumners C: Cytokine-stimulated inducible nitric oxide synthase
expression in astroglia: role of Erk mitogen-activated protein
kinase and NF-kappaB. Glia. 41:152–160. 2003. View Article : Google Scholar : PubMed/NCBI
|
26
|
Mercurio F and Manning AM: NF-kappaB as a
primary regulator of the stress response. Oncogene. 18:6163–6171.
1999. View Article : Google Scholar : PubMed/NCBI
|
27
|
Klemm S and Ruland J: Inflammatory signal
transduction from the Fc epsilon RI to NF-kappa B. Immunobiology.
211:815–820. 2006. View Article : Google Scholar : PubMed/NCBI
|
28
|
Sonis ST: The biologic role for nuclear
factor-kappaB in disease and its potential involvement in mucosal
injury associated with anti-neoplastic therapy. Crit Rev Oral Biol
Med. 13:380–389. 2002. View Article : Google Scholar : PubMed/NCBI
|
29
|
Kim EK and Choi EJ: Pathological roles of
MAPK signaling pathways in human diseases. Biochim Biophys Acta.
1802:396–405. 2010. View Article : Google Scholar : PubMed/NCBI
|
30
|
Huang P, Han J and Hui L: MAPK signaling
in inflammation-associated cancer development. Protein Cell.
1:218–226. 2010. View Article : Google Scholar : PubMed/NCBI
|
31
|
Kaminska B, Gozdz A, Zawadzka M,
Ellert-Miklaszewska A and Lipko M: MAPK signal transduction
underlying brain inflammation and gliosis as therapeutic target.
Anat Rec (Hoboken). 292:1902–1913. 2009. View Article : Google Scholar : PubMed/NCBI
|